{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:46:41Z","timestamp":1791550001009,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007301","name":"Kunming University of Science and Technology","doi-asserted-by":"publisher","award":["KUST-PE2022006Y"],"award-info":[{"award-number":["KUST-PE2022006Y"]}],"id":[{"id":"10.13039\/501100007301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170280"],"award-info":[{"award-number":["82170280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1803125"],"award-info":[{"award-number":["U1803125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7232093"],"award-info":[{"award-number":["7232093"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jare.2024.12.016","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T12:28:22Z","timestamp":1734092902000},"page":"553-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Natural small molecule hinokitone mitigates NASH fibrosis by targeting regulation of FXR-mediated hepatocyte apoptosis"],"prefix":"10.1016","volume":"76","author":[{"given":"Ze-Jiang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0181-2927","authenticated-orcid":false,"given":"Ying-Kun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Tian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Tong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Kang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2024.12.016_b0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.semcancer.2023.04.010","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: insights in epidemiology, pathogenesis, imaging, prevention and therapy","author":"Polyzos","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jare.2024.12.016_b0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2024.12.016_b0015","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","author":"Sheka","year":"2020","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"10.1016\/j.jare.2024.12.016_b0020","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.30664","article-title":"The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials","volume":"2019","author":"Sanyal","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2024.12.016_b0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jare.2024.12.016_b0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","author":"Higashi","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jare.2024.12.016_b0035","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jare.2024.12.016_b0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","article-title":"Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis","author":"Feldstein","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jare.2024.12.016_b0045","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41575-018-0065-y","article-title":"Apoptosis and necroptosis in the liver: a matter of life and death","author":"Schwabe","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jare.2024.12.016_b0050","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","article-title":"FXR agonists in NASH treatment","author":"Adorini","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jare.2024.12.016_b0055","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/hep.26714","article-title":"Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis","volume":"2014","author":"Xu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2024.12.016_b0060","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ebiom.2018.10.028","article-title":"Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jare.2024.12.016_b0065","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1080\/14786419.2015.1022544","article-title":"Chemical composition and antibacterial activity of the essential oil from Agathis dammara (Lamb.) rich fresh leaves","author":"Chen","year":"2015","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.jare.2024.12.016_b0070","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2174\/1389557520666201117110834","article-title":"A review of research progress on Agathis dammara and its application prospects for cardiovascular diseases and fatty liver disease","author":"Wang","year":"2021","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.jare.2024.12.016_b0075","unstructured":"Rong Qi, Yingkun Qiu, Ankang Peng, Anyi Wang, Shanshan Yue. Application of agathis dammara extract in the preparation of products against non-alcoholic fatty liver disease: China, CN201911255818.7.2021-06-11."},{"key":"10.1016\/j.jare.2024.12.016_b0080","article-title":"Hinokione: an abietene diterpene with pancreatic beta cells regeneration and hypoglycemic activity, and other derivatives with novel structures from the woods of Agathis dammara","author":"Wang","year":"2024","journal-title":"J Nat Med"},{"key":"10.1016\/j.jare.2024.12.016_b0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","author":"Tsuchida","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jare.2024.12.016_b0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1586\/egh.11.16","article-title":"Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?","author":"Machado","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jare.2024.12.016_b0095","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.LAB.0000069036.63405.5C","article-title":"Apoptotic body engulfment by a human stellate cell line is profibrogenic","volume":"2003","author":"Canbay","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.jare.2024.12.016_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcmgh.2014.11.005","article-title":"Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis","author":"Hirsova","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jare.2024.12.016_b0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte notch activation induces liver fibrosis in nonalcoholic steatohepatitis","author":"Zhu","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jare.2024.12.016_b0110","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/1440-1681.12102","article-title":"A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice","author":"Kubota","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jare.2024.12.016_b0115","article-title":"Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jare.2024.12.016_b0120","article-title":"Ginsenoside Rg5 inhibits lipid accumulation and hepatocyte apoptosis via the Notch1 signaling pathway in NASH mice","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jare.2024.12.016_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101231","article-title":"Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies","author":"Parola","year":"2024","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.jare.2024.12.016_b0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/liv.15157","article-title":"Integrins as a drug target in liver fibrosis","author":"Rahman","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jare.2024.12.016_b0135","doi-asserted-by":"crossref","unstructured":"S. Y. Tian, S. M. Chen, C. X. Pan, and Y. Li. FXR: structures, biology, and drug development for NASH and fibrosis diseases. Acta Pharmacol. Sin. (2022), 1120-1132. DOI 10.1038\/s41401-021-00849-4.","DOI":"10.1038\/s41401-021-00849-4"},{"key":"10.1016\/j.jare.2024.12.016_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166235","article-title":"Nuclear receptors in liver fibrosis","author":"Konigshofer","year":"2021","journal-title":"Biochim Biophys Acta-Mol Basis Dis"},{"key":"10.1016\/j.jare.2024.12.016_b0145","article-title":"SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis","volume":"240","author":"Zhou","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2024.12.016_b0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.phrs.2018.02.033","article-title":"Disruption of TFGbeta-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand","author":"Carino","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jare.2024.12.016_b0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.apsb.2022.08.019","article-title":"SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR","author":"Cui","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jare.2024.12.016_b0160","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.26971","article-title":"SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling","author":"Garcia-Rodriguez","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2024.12.016_b0165","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.25961","article-title":"Deficiency of carboxylesterase 1\/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia","author":"Quiroga","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2024.12.016_b0170","doi-asserted-by":"crossref","unstructured":"C. Gan, J. Wang, A. Martinez-Chavez, M. Hillebrand, N. de Vries, J. Beukers, E. Wagenaar, Y. Wang, M. C. Lebre, H. Rosing, S. Klarenbeek, R. B. Ali, C. Pritchard, I. Huijbers, J. H. Beijnen, and A. H. Schinkel. Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism. Acta Pharm. Sin. B (2023), 618-631. 10.1016\/j.apsb.2022.10.017.","DOI":"10.1016\/j.apsb.2022.10.017"},{"key":"10.1016\/j.jare.2024.12.016_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115250","article-title":"Emerging role of carboxylesterases in nonalcoholic fatty liver disease","author":"Liu","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jare.2024.12.016_b0180","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jhep.2019.11.024","article-title":"A randomized, placebo-controlled trial of emricasan in patients with NASH and F1\u2013F3 fibrosis","author":"Harrison","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jare.2024.12.016_b0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials","author":"Harrison","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jare.2024.12.016_b0190","article-title":"Obeticholic acid for the treatment of NASH","volume":"66","author":"Hindson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jare.2024.12.016_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115965","article-title":"Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis","author":"Jiang","year":"2023","journal-title":"J Ethnopharmacol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123224005939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123224005939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T21:02:54Z","timestamp":1759784574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123224005939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"alternative-id":["S2090123224005939"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2024.12.016","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural small molecule hinokitone mitigates NASH fibrosis by targeting regulation of FXR-mediated hepatocyte apoptosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2024.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}